Viewing nowSitaren 50 mg (Sitagliptin Hydrochloride Hydrate)
Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
NexPharm Korea Co., Ltd.

MFDS item code 202005702 · Approved 2020.08.07 · Insurance code 662504570
Improvement in blood sugar control for type 2 diabetes
This medication is used as an adjunct to diet and exercise to improve blood sugar control in patients with type 2 diabetes. It can be administered as monotherapy, and in cases where sufficient blood sugar control is difficult with monotherapy for patients who have not previously received antidiabetic drug treatment, it may be used in combination with metformin. Additionally, it can be combined with sulfonylureas, metformin, thiazolidinediones, or insulin in cases where blood glucose control is not sufficient through monotherapy. Furthermore, for patients who find blood glucose control challenging with multiple drug regimens, adding this medication can lead to further improved blood sugar control. Thus, this medication can be effectively utilized in various situations to aid in blood sugar control and diabetes treatment.
The recommended dosage is 100 mg once daily as monotherapy or in combination with other medications, with a maximum daily dosage of 100 mg. For patients with renal impairment, the dosage should be adjusted according to kidney function. - For mild and moderate renal impairment (eGFR above 45 but below 90), dosage adjustment is not necessary. - For moderate renal impairment (eGFR above 30 but below 45), administer 50 mg once daily. - Moderate
This medication is used for diabetes treatment, and there are several precautions to observe when taking it. First, there is a possibility of a rare severe allergic reaction while taking this medication; if symptoms such as skin rash, difficulty breathing, or swelling of the face or neck occur, immediately discontinue use and consult a physician. Second, this medication may cause a serious side effect known as pancreatitis, which is inflammation of the pancreas; therefore, if there is abdominal pain, vomiting, or severe abdominal discomfort, it is essential to notify healthcare personnel immediately. Third, this medication should not be taken by patients with type 1 diabetes, diabetic ketoacidosis, or those who have hypersensitivity to this medication or its components. Fourth, patients with impaired kidney function should have their dosage adjusted, and kidney function tests should be performed before and during the medication. Fifth, when taken with sulfonylureas or insulin, there may be an increased risk of hypoglycemia, so patients should be vigilant for symptoms of low blood sugar and check their blood glucose frequently if necessary. Sixth, severe joint pain or blistering skin diseases may occur during treatment with this medication, and if these symptoms appear, it is crucial to inform a physician immediately and consider discontinuation of the medication. Seventh, it is not recommended for pregnant or breastfeeding women, and safety has not been confirmed for children under 18 years of age. Finally, in case of overdose, it is essential to visit a medical institution for appropriate treatment and monitoring, as some of the medication may be removed through hemodialysis. During the use of this medication, it is crucial to consult healthcare personnel if any of the above symptoms or abnormalities occur in order to receive appropriate measures.
Urticaria, angioedema, anaphylaxis, exfoliative skin disorders like Stevens-Johnson syndrome, acute pancreatitis, severe hypoglycemia, acute renal failure, severe arthralgia and complications with disability, bullous pemphigoid, pneumonia, diabetic complications, metabolic acidosis, falls, cardiac arrest, rash
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air exposure, and it is advisable to keep it at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness and prevent degradation.
Light yellow-pink, round, biconvex film-coated tablets
30 tablets/box [(10 tablets/PTP x 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
NexPharm Korea Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Korea United Pharm., Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.